Legangneux, Eric,Wallstroem, Erik,Bouillot, Philippe Michael Rene,Reynaud, Emeric,Dahlke, Frank
申请号：
AU2020203107
公开号：
AU2020203107A1
申请日:
2020.05.12
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020203107A120200528.pdf#####Abstract The present invention relates to siponimod (BAF312) for use in the treatment of an autoimmune disease, wherein an immediate release dosage form is administered once daily to a patient as maintenance regimen and wherein the patient has experienced a specific titration regimen with siponimod beforehand.
